Burundi vs Senegal: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Burundi
0.4%
in 2024
Senegal
0.4%
in 2024
Burundi rank
59th
Senegal rank
59th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Burundi
- Senegal
How they compare
Burundi currently reports 0.4% against 0.4% in Senegal, a difference of 0.0%.
Across all 10 years both countries report, Senegal has been ahead every year.
Burundi ranks 59th and Senegal ranks 59th of 215 countries.
Senegal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burundi | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.8% | 0.4% | Senegal |
| 2020s | 0.4% | 0.5% | 0.1% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Burundi or Senegal?
- Burundi, at 0.4% against 0.4% in Senegal as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Burundi and Senegal?
- 0.0%, with Burundi ahead.
- How many years of comparable data are there for Burundi and Senegal?
- 10 years are reported by both, from 2015 to 2024.
- How do Burundi and Senegal rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Burundi ranks 59th and Senegal ranks 59th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.